These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27238373)

  • 1. In permanent atrial fibrillation, PDE3 reduces force responses to 5-HT, but PDE3 and PDE4 do not cause the blunting of atrial arrhythmias.
    Berk E; Christ T; Schwarz S; Ravens U; Knaut M; Kaumann AJ
    Br J Pharmacol; 2016 Aug; 173(16):2478-89. PubMed ID: 27238373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillation.
    Dolce B; Christ T; Grammatika Pavlidou N; Yildirim Y; Reichenspurner H; Eschenhagen T; Nikolaev VO; Kaumann AJ; Molina CE
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):291-298. PubMed ID: 32949251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogenic changes of the control by phosphodiesterase-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT(4) receptors.
    Galindo-Tovar A; Vargas ML; Escudero E; Kaumann AJ
    Br J Pharmacol; 2009 Jan; 156(2):237-49. PubMed ID: 19154438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats.
    Kaumann AJ; Galindo-Tovar A; Escudero E; Vargas ML
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):421-30. PubMed ID: 19693491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (-)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium.
    Galindo-Tovar A; Vargas ML; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Apr; 379(4):379-84. PubMed ID: 19005642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
    Galindo-Tovar A; Kaumann AJ
    Br J Pharmacol; 2008 Feb; 153(4):710-20. PubMed ID: 18084319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles.
    Afzal F; Andressen KW; Mørk HK; Aronsen JM; Sjaastad I; Dahl CP; Skomedal T; Levy FO; Osnes JB; Qvigstad E
    Br J Pharmacol; 2008 Dec; 155(7):1005-14. PubMed ID: 18846035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inotropy and L-type Ca2+ current, activated by beta1- and beta2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart.
    Christ T; Galindo-Tovar A; Thoms M; Ravens U; Kaumann AJ
    Br J Pharmacol; 2009 Jan; 156(1):62-83. PubMed ID: 19133992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of both noradrenaline and CGP12177, mediated through human beta1 -adrenoceptors, are reduced by PDE3 in human atrium but PDE4 in CHO cells.
    Kaumann A; Semmler AB; Molenaar P
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):123-31. PubMed ID: 17318500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of cardiac beta1- and beta2-adrenoceptors of newborn piglets: role of phosphodiesterases PDE3 and PDE4.
    Galindo-Tovar A; Vargas ML; Kaumann AJ
    Eur J Pharmacol; 2010 Jul; 638(1-3):99-107. PubMed ID: 20406625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.
    Molenaar P; Christ T; Hussain RI; Engel A; Berk E; Gillette KT; Chen L; Galindo-Tovar A; Krobert KA; Ravens U; Levy FO; Kaumann AJ
    Br J Pharmacol; 2013 Jun; 169(3):528-38. PubMed ID: 23489141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of β2 -adrenoceptor-mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricle.
    Afzal F; Aronsen JM; Moltzau LR; Sjaastad I; Levy FO; Skomedal T; Osnes JB; Qvigstad E
    Br J Pharmacol; 2011 Jan; 162(1):54-71. PubMed ID: 21133887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal Spontaneous Firing of Rabbit Sinoatrial Node Cells Is Regulated by Dual Activation of PDEs (Phosphodiesterases) 3 and 4.
    Vinogradova TM; Sirenko S; Lukyanenko YO; Yang D; Tarasov KV; Lyashkov AE; Varghese NJ; Li Y; Chakir K; Ziman B; Lakatta EG
    Circ Arrhythm Electrophysiol; 2018 Jun; 11(6):e005896. PubMed ID: 29880528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective changes in cytosolic β-adrenergic cAMP signals and L-type Calcium Channel regulation by Phosphodiesterases during cardiac hypertrophy.
    Abi-Gerges A; Castro L; Leroy J; Domergue V; Fischmeister R; Vandecasteele G
    J Mol Cell Cardiol; 2021 Jan; 150():109-121. PubMed ID: 33184031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterases 2, 3 and 4 can decrease cardiac effects of H
    Neumann J; Voss R; Laufs U; Werner C; Gergs U
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1215-1229. PubMed ID: 33576869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct patterns of constitutive phosphodiesterase activity in mouse sinoatrial node and atrial myocardium.
    Hua R; Adamczyk A; Robbins C; Ray G; Rose RA
    PLoS One; 2012; 7(10):e47652. PubMed ID: 23077656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic adenosine monophosphate phosphodiesterase type 4 protects against atrial arrhythmias.
    Molina CE; Leroy J; Richter W; Xie M; Scheitrum C; Lee IO; Maack C; Rucker-Martin C; Donzeau-Gouge P; Verde I; Llach A; Hove-Madsen L; Conti M; Vandecasteele G; Fischmeister R
    J Am Coll Cardiol; 2012 Jun; 59(24):2182-90. PubMed ID: 22676938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which phosphodiesterase can decrease cardiac effects of 5-HT
    Neumann J; Käufler B; Gergs U
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Aug; 392(8):991-1004. PubMed ID: 31016326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol induces greater control of β2- than β 1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium.
    Molenaar P; Christ T; Berk E; Engel A; Gillette KT; Galindo-Tovar A; Ravens U; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):629-40. PubMed ID: 24668024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of phosphodiesterases and cGMP on cAMP generation and on phosphorylation of phospholamban and troponin I by 5-HT4 receptor activation in porcine left atrium.
    Weninger S; De Maeyer JH; Lefebvre RA
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):671-84. PubMed ID: 23549671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.